RN7SKP23

Across TCGA pan-cancer cohorts, RN7SKP23 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RN7SKP23 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SKP23 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SKP23 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

BRCA, UCS, and BLCA are the cancer types where RN7SKP23 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.614	0.535	.004	39	view →
UCS	DFS	Tertile	IV	0.956	0.250	.024	30	view →
BLCA	OS	Quartile	All	0.613	0.337	.003	29	view →
READ	OS	Tertile	All	0.804	0.262	.002	26	view →
LIHC	DFS	Median	All	0.498	0.585	.027	12	view →
KIRC	DFS	Median	All	0.483	0.679	.019	10	view →
KICH	DFS	Tertile	III,IV	0.303	1.000	.033	8	view →
ESCA	OS	Tertile	IV	0.243	0.738	.024	6	view →
LUAD	DFS	Quartile	IV	0.276	1.000	.049	6	view →
OV	OS	Median	IV	0.640	0.828	.024	4	view →
THYM	DFS	Quartile	All	0.662	1.000	.029	3	view →
CHOL	DFS	Median	III,IV	0.133	0.779	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RN7SKP23–BRCA (OS)

Open the BRCA breakdown →